As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- Prevention Bike-A-Thon to benefit MA Breast Cancer Coalitionon April 13, 2021 at 3:22 am
Massachusetts Breast Cancer Coalition (MBCC) is hosting its first Annual Bike for Prevention Bike-A-Thon virtually on a local and national scale from Monday, April 19 to Sunday, April 25. The ...
- BC Platforms Partners with Australian Tissue Bank (ABCTB) to Improve Breast Cancer Treatment Outcomeson April 12, 2021 at 11:11 pm
... consists of a large collection of breast cancer and normal breast tissue samples, as well as blood samples which are taken from women diagnosed with breast cancer together with information ...
- Kilpatrick reflects on 1-year anniversary of cancer diagnosison April 12, 2021 at 10:05 pm
The then 33-year-old was 38 weeks pregnant with her first son — and second child — when she was diagnosed with Stage 3 papillary breast cancer. Minutes later, her 2-year-old daughter, Riley, walked in ...
- Obesity may increase a breast cancer survivor's risk for other cancers, study sayson April 12, 2021 at 3:21 pm
but a new study suggests that among breast cancer survivors it also increases the chances of a person will be diagnosed with a second cancer. In the United States, there are almost 4 million breast ...
- Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast canceron April 12, 2021 at 1:33 pm
Cardiotoxic manifestation associated with breast cancer treatment by anthracycline regimen increases patients’ susceptibility to myocardial injury, reduction in left ventricular ejection fraction and ...
- Weight linked to risk of second cancer after breast canceron April 12, 2021 at 7:49 am
Breast cancer survivors who are overweight have a statistically significant increased risk of developing second primary cancers, according to results from a study conducted by Kaiser Permanente ...
- Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER statuson April 12, 2021 at 6:50 am
Fig. 6: Reduced expression of IQGAP2 promotes tumor growth in mouse model. The search for molecular markers, which could assist in early diagnosis of breast cancer irrespective of the molecular ...
- Fitness: App helps breast cancer patients, survivors keep movingon April 11, 2021 at 7:40 am
While the survival rate of breast cancer has been on the rise since 1987, it’s still the most frequently diagnosed cancer among Canadian women and ranks second in cancer-related deaths of women. But ...
- 4 Your Community: Breast Cancer Research Foundationon April 10, 2021 at 11:38 am
PAULA EBBEN: The one thing that I was reading through that was-- it really hit me this time around, and I have to read it so I make sure I have it correct-- is that for the first time ever, breast ...
via Bing News